###begin article-title 0
TRAF6 Is Required for Generation of the B-1a B Cell Compartment as well as T Cell-Dependent and -Independent Humoral Immune Responses
###end article-title 0
###begin p 1
Conceived and designed the experiments: TK YC. Performed the experiments: TK TSK AJ MW YK EFP TY MY TK. Analyzed the data: TK TSK AJ MW YK EFP TY AY MY TK SA JGM. Contributed reagents/materials/analysis tools: AY SA. Wrote the paper: TK AJ JGM YC.
###end p 1
###begin p 2
###xml 332 337 332 337 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TRAF6</italic>
###xml 944 945 944 945 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 682 686 <span type="species:ncbi:10090">mice</span>
###xml 720 724 <span type="species:ncbi:10090">mice</span>
TNF receptor superfamily members, such as CD40 and the Toll-like receptors (TLRs), regulate many aspects of B cell differentiation and activation. TRAF6 is an intracellular signaling adaptor molecule for these receptors, but its role in B cells has not been clarified by previous genetic approaches, as the systemic deletion of the TRAF6 gene results in perinatal lethality. Here we show that B cell-specific TRAF6 deficiency results in a reduced number of mature B cells in the bone marrow and spleen. Optimal T cell-dependent (TD) antigen responses, as characterized by isotype switching and long-lived plasma cell generation, are also impaired in B cell-specific TRAF6-deficient mice. B cell-specific TRAF6-deficient mice also exhibit lower levels of serum IgM and IgG2b and defective antigen-specific IgM production in response to T cell-independent (TI) antigens. Unexpectedly, TRAF6-deficient B cell progenitors are unable to generate CD5+ B-1 cells. These results reveal critical roles for TRAF6 in TD and TI humoral immune responses and in inductive fate decisions necessary to generate the B-1 B cell compartment.
###end p 2
###begin title 3
Introduction
###end title 3
###begin p 4
###xml 247 250 247 250 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004736-Akira1">[1]</xref>
###xml 252 255 252 255 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004736-DeFranco1">[2]</xref>
###xml 257 260 257 260 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004736-Krieg1">[3]</xref>
###xml 262 265 262 265 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004736-Medzhitov1">[4]</xref>
###xml 563 566 563 566 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004736-Banchereau1">[5]</xref>
###xml 568 571 568 571 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004736-Bishop1">[6]</xref>
###xml 702 705 702 705 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004736-Dempsey1">[7]</xref>
###xml 731 734 731 734 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004736-Cao1">[8]</xref>
###xml 736 739 736 739 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004736-Chung1">[9]</xref>
###xml 792 796 792 796 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004736-Kobayashi1">[10]</xref>
###xml 1028 1032 1024 1028 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004736-Darnay1">[11]</xref>
###xml 1034 1038 1030 1034 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004736-Pullen1">[12]</xref>
###xml 1040 1044 1036 1040 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004736-Ye1">[13]</xref>
Ligands for the Toll-like receptors (TLRs), such as lipopolysaccharide (LPS) and CpG-DNA, are powerful B cell mitogens, and they also induce proinflammatory cytokines such as interleukin (IL)-6 and the surface molecules CD40, B-7 and MHC class II [1], [2], [3], [4]. The tumor necrosis factor receptor (TNFR) superfamily member CD40 similarly induces not only clonal B cell expansion but also T cell-dependent (TD) responses, such as germinal center (GC) formation, antibody isotype switching, affinity maturation and differentiation into long-lived plasma cells [5], [6]. TNF receptor-associated factor 6 (TRAF6), a member of the TRAF family of cytoplasmic adaptors, transduces signals from the TNFRs [7] as well as from the TLRs [8], [9], thereby playing a critical role in innate immunity [10]. TRAF6 is recruited to the motif PXEXXAr/Ac, which is found in the IL-1 receptor-associated kinase (IRAK) adaptor molecules and in the cytoplasmic portion of TNFR family members like CD40 and receptor activator of NF-kappaB (RANK) [11], [12], [13]. TRAF6 mediates the activation of mitogen-activated protein (MAP) kinases such as p38, Erk and JNK, and NF-kappaB transcription factors.
###end p 4
###begin p 5
###xml 260 264 260 264 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004736-Ye1">[13]</xref>
###xml 355 363 355 363 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 569 573 569 573 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004736-Ahonen1">[14]</xref>
###xml 575 579 575 579 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004736-Jabara1">[15]</xref>
###xml 697 701 697 701 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004736-Ahonen1">[14]</xref>
###xml 829 833 829 833 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004736-Jabara1">[15]</xref>
###xml 1052 1056 1052 1056 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004736-Ahonen1">[14]</xref>
###xml 1117 1121 1117 1121 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004736-Jabara1">[15]</xref>
###xml 492 507 <span type="species:ncbi:10090">transgenic mice</span>
TRAFs 1, 2, 3, 5 and 6 are recruited to specific domains in the cytoplasmic tail of CD40. The binding site for TRAF6 is distinct from that of other TRAFs (PXQXT motif), and there are structural differences between receptor recognition by TRAF6 and other TRAFs [13]. It has been shown that the various TRAFs have some unique and some overlapping functions in vitro; however, the roles of each TRAF downstream of CD40 in B cells are not fully understood. Recently, two separate groups examined transgenic mice with CD40 mutations that lack one or both TRAF binding sites [14], [15]. One study found that TRAF6 plays a critical role in antibody affinity maturation and the generation of plasma cells [14], whereas the other study concluded that TRAF6 has no discernible role in CD40-mediated activation and antibody class switching [15]. It is difficult to establish the importance of TRAF6 in B cell function from these two studies. The functional readouts examined were different; in addition, in one study the mutant CD40 molecule was widely expressed [14], while in the other it was expressed exclusively in B cells [15]. Finally, neither of these studies was designed to determine CD40-independent functions of TRAF6 in B cells.
###end p 5
###begin p 6
###xml 101 105 101 105 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TRAF</italic>
###xml 155 163 155 163 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in utero</italic>
###xml 370 374 370 374 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004736-Lomaga1">[16]</xref>
###xml 376 380 376 380 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004736-Naito1">[17]</xref>
###xml 545 549 545 549 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004736-Naito1">[17]</xref>
###xml 146 150 <span type="species:ncbi:10090">mice</span>
###xml 261 265 <span type="species:ncbi:10090">mice</span>
###xml 523 527 <span type="species:ncbi:10090">mice</span>
###xml 716 720 <span type="species:ncbi:10090">mice</span>
There are difficulties associated with examining the role of different TRAFs in mature B cells using TRAF gene deletions. TRAF2-, 3-, 6-deficient mice die in utero or shortly after birth, suffering from multiple abnormalities in various organs. TRAF6-deficient mice develop osteopetrosis and occlusion of the bone marrow (BM) cavities from a lack of osteoclast function [16], [17]. The BM is an anatomically important site for early B cell development and for antibody production by plasma cells. Moreover, TRAF6-deficient mice lack lymph nodes [17] and therefore cannot support normal T cell-B cell interactions during the course of an immune response. Not unexpectedly, there are very few splenic B cells in these mice (approximately 5%, data not shown). Hence, analysis of the physiologic function of TRAF6 in B cells has not been amenable to genetic approaches.
###end p 6
###begin p 7
###xml 194 199 194 199 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TRAF6</italic>
###xml 219 222 219 222 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">lox</italic>
###xml 620 621 620 621 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 147 151 <span type="species:ncbi:10090">mice</span>
###xml 177 181 <span type="species:ncbi:10090">mice</span>
###xml 245 249 <span type="species:ncbi:10090">mice</span>
###xml 343 347 <span type="species:ncbi:10090">mice</span>
In order to clarify the physiologic role of TRAF6 in the regulation of B cell development and function, we created B cell-specific TRAF6-deficient mice by crossing floxed TRAF6 mice (in which a TRAF6 exon is flanked by loxP sites) with CD19-Cre mice. TRAF6 appears to influence several processes in B cell development and function. The mutant mice have fewer mature B cells in the BM and spleen and mount sub-optimal TD-antigen responses. Additionally, baseline IgM production as well as T cell-independent (TI) antigen-specific IgM production is severely impaired, most likely as a result of the complete absence of CD5+ B-1 cells (B-1a cells) in the peritoneal cavity. Our findings suggest novel functions for TRAF6, which appears to be required for both B-1 and B-2 cell homeostasis and to play a role in both in TI and TD humoral immune responses.
###end p 7
###begin title 8
Results
###end title 8
###begin title 9
###xml 46 50 <span type="species:ncbi:10090">mice</span>
Generation of B cell-specific TRAF6-deficient mice
###end title 9
###begin p 10
###xml 173 178 169 174 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TRAF6</italic>
###xml 213 222 209 218 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">flox/flox</sup>
###xml 228 232 224 228 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004736-King1">[18]</xref>
###xml 373 378 369 374 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TRAF6</italic>
###xml 471 477 467 473 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0004736-g001">Fig. 1</xref>
###xml 516 521 512 517 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Cre/+</sup>
###xml 526 535 522 531 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">flox/flox</sup>
###xml 748 753 744 749 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Cre/+</sup>
###xml 758 764 754 760 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">flox/&#8722;</sup>
###xml 771 777 767 773 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0004736-g001">Fig. 1</xref>
###xml 790 795 786 791 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Cre/+</sup>
###xml 800 809 796 805 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">flox/flox</sup>
###xml 818 823 814 819 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Cre/+</sup>
###xml 828 834 824 830 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">flox/&#8722;</sup>
###xml 116 120 <span type="species:ncbi:10090">mice</span>
###xml 135 139 <span type="species:ncbi:10090">mice</span>
###xml 223 227 <span type="species:ncbi:10090">mice</span>
###xml 260 264 <span type="species:ncbi:10090">mice</span>
###xml 536 540 <span type="species:ncbi:10090">mice</span>
###xml 703 707 <span type="species:ncbi:10090">mice</span>
###xml 765 769 <span type="species:ncbi:10090">mice</span>
###xml 835 839 <span type="species:ncbi:10090">mice</span>
###xml 880 884 <span type="species:ncbi:10090">mice</span>
In order to study the physiologic functions of TRAF6 in B lymphocytes, we generated B cell-specific TRAF6-deficient mice (TRAF6-DeltaB mice). To generate offspring in which TRAF6 was deleted only in B cells, TRAF6flox/flox mice [18] were crossed with CD19-Cre mice, in which the expression of Cre recombinase is driven by the CD19 promoter. B cell-specific deletion of the TRAF6 gene was confirmed by polymerase chain reaction (data not shown) and western blot analysis (Fig. 1). Purified B cells from spleen of CD19Cre/+TRAF6flox/flox mice contained almost undetectable levels of TRAF6 protein, although a substantial amount of TRAF6 was present in non-B splenocytes as well as in B cells from control mice. Similar results were obtained from CD19Cre/+TRAF6flox/- mice (Fig. 1). Thus, CD19Cre/+TRAF6flox/flox and CD19Cre/+TRAF6flox/- mice were used interchangeably. TRAF6-DeltaB mice were born at the expected Mendelian ratio and exhibited normal growth rates, without inflammatory lesions or osteopetrosis.
###end p 10
###begin title 11
###xml 39 43 <span type="species:ncbi:10090">mice</span>
Generation of B cell specific TRAF6 KO mice.
###end title 11
###begin p 12
###xml 42 45 42 45 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Cre</italic>
(a) Southern blot analysis to confirm the Cre-mediated deletion of the floxed fragment. (b) Western blot analysis to demonstrate specific deletion of TRAF6 in B cells. Lysates blotted with anti-TRAF6 or anti-actin from B cells and non-B cells are shown.
###end p 12
###begin title 13
TRAF6 deficiency in B cells results in defective proliferation, IL-6 production and signaling in response to TLR ligands and anti-CD40
###end title 13
###begin p 14
###xml 119 122 119 122 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004736-Akira1">[1]</xref>
###xml 124 127 124 127 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004736-Medzhitov1">[4]</xref>
###xml 129 132 129 132 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004736-Banchereau1">[5]</xref>
###xml 134 137 134 137 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004736-Bishop1">[6]</xref>
###xml 224 231 220 227 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ex vivo</italic>
###xml 291 298 287 294 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0004736-g002">Fig. 2a</xref>
###xml 601 608 589 596 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0004736-g002">Fig. 2b</xref>
###xml 219 223 <span type="species:ncbi:10090">mice</span>
TLRs and CD40, which stimulate B cells upon interaction with their respective ligands, induce the recruitment of TRAF6 [1], [4], [5], [6]. Therefore, we first examined proliferation of splenic B cells from TRAF6-DeltaB mice ex vivo in response to LPS, CpG-DNA, anti-CD40 Ab and anti-BCR Ab (Fig. 2a). Proliferation of TRAF6-DeltaB B cells in response to LPS, CpG-DNA and anti-CD40 Ab was severely impaired, while proliferation induced by BCR crosslinking was comparable to the control B cells. In addition, LPS- and CpG-DNA-induced production of IL-6 was nearly abolished in the TRAF6-DeltaB B cells (Fig. 2b).
###end p 14
###begin title 15
Defective proliferation, IL-6 production and signal activation of TRAF6-deficient B cells in response to TLR ligands and anti-CD40 antibody.
###end title 15
###begin p 16
###xml 86 94 82 90 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 545 553 527 535 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
(a) Proliferative response of splenic B cells from control or TRAF6-DeltaB stimulated in vitro with varying doses of LPS, CpG-DNA, anti-CD40 antibody or anti-BCR antibody. Results are representative of at least 4 different experiments. Data are presented as mean+/-SD. (b) IL-6 production in media supernatants from splenic B cells cultured for 2 days with LPS (10 microg/ml), CpG-DNA (1 microM) or anti-BCR antibody (20 microg/ml). (c) Western blot analysis of phosphorylation of the indicated proteins in lysates of splenic B cells stimulated in vitro with CpG-DNA (4 microM), anti-CD40 antibody (8 microg/ml) or pervanadate (PV) for the indicated times. Sequential immunoblots with antibodies to the phosphorylated (indicated by "p-") and total protein are compared. Results are representative of at least 4 different experiments.
###end p 16
###begin p 17
###xml 160 163 152 155 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004736-Akira1">[1]</xref>
###xml 165 168 157 160 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004736-Bishop1">[6]</xref>
###xml 410 430 382 402 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0004736-g002">Fig. 2c, left panels</xref>
###xml 581 602 553 574 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0004736-g002">Fig. 2c, right panels</xref>
###xml 404 408 <span type="species:ncbi:10090">mice</span>
Stimulation by TLR ligands or CD40 ligation causes the phosphorylation and activation of MAP kinases as well as phosphorylation and degradation of IkappaBalpha [1], [6]. Control B cells stimulated with CpG-DNA induced phosphorylation of p38, Erk, JNK, Akt and IkappaBalpha, as well as IkappaBalpha degradation within 15 min. However, these events were significantly impaired in B cells from TRAF6-DeltaB mice (Fig. 2c, left panels). Notably, phosphorylation of p38 was undetectable in TRAF6-deficient B cells. Similar results were observed in B cells stimulated with anti-CD40 Ab (Fig. 2c, right panels) or LPS (data not shown). These results suggest that TRAF6 mediates signals from TLRs and CD40 that regulate B cell proliferation and cytokine production.
###end p 17
###begin title 18
TRAF6 is critical for mature B cell fate determination
###end title 18
###begin p 19
###xml 181 200 173 192 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0004736-g003">Fig. 3a, top panels</xref>
###xml 297 300 289 292 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">low</sup>
###xml 303 304 295 296 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 307 308 299 300 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;</sup>
###xml 386 403 374 391 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0004736-g003">Fig 3a, top panel</xref>
###xml 68 72 <span type="species:ncbi:10090">mice</span>
###xml 143 147 <span type="species:ncbi:10090">mice</span>
###xml 175 179 <span type="species:ncbi:10090">mice</span>
###xml 380 384 <span type="species:ncbi:10090">mice</span>
We next examined B cell development and homeostasis in TRAF6-DeltaB mice. The early developmental subsets of B cells in the BM of TRAF6-DeltaB mice were comparable to control mice (Fig. 3a, top panels), with no obvious difference in pre- and pro-B cell subsets (data not shown). The ratios of B220lowIgM+IgD- immature B cells were also comparable between TRAF6-DeltaB and control mice (Fig 3a, top panel).
###end p 19
###begin title 20
TRAF6 is required for mature B cell homeostasis.
###end title 20
###begin p 21
###xml 349 350 345 346 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 782 783 778 779 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 65 69 <span type="species:ncbi:10090">mice</span>
###xml 303 307 <span type="species:ncbi:10090">mice</span>
###xml 773 777 <span type="species:ncbi:10090">mice</span>
###xml 977 981 <span type="species:ncbi:10090">mice</span>
(a) Flow cytometric analysis of BM from control and TRAF6-DeltaB mice stained with the indicated antibodies (top-most and middle panels). The percentages of encircled areas are indicated. Pro+Pre, pro-B and pre-B cells; Imm, immature B cells; Rec, recirculating B cells. Results are representative of 5 mice. Lowest panel, absolute cell numbers; *, p<0.005. (b) Similar analysis of total spleen cells. Total B cells are shown in the topmost panels; mature (Mat) and immature (Imm) B cells are compared in the middle panels. The lowest panels compare the follicular (FO) and MZ sub-populations within the mature B cell gate shown in the middle panels. Cell numbers of each B cell subset in the spleen are shown in the lowest panels. Results are representative of at least 4 mice; *, p<0.05. (c) Splenic microarchitecture visualized by immunohistochemical staining with anti-B220 (red), anti-CD3 (blue) and anti-MOMA1 (green) antibodies. Results are representative of at least 5 mice.
###end p 21
###begin p 22
###xml 62 66 62 66 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">high</sup>
###xml 69 70 69 70 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 73 74 73 74 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 221 251 209 239 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0004736-g003">Fig. 3a, top and middle panels</xref>
###xml 313 328 301 316 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0004736-g003">Fig. 3a, bottom</xref>
###xml 377 378 365 366 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 382 383 370 371 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 495 516 475 496 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0004736-g003">Fig. 3b, upper panels</xref>
###xml 606 609 586 589 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">low</sup>
###xml 612 616 592 596 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">high</sup>
###xml 621 622 601 602 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;</sup>
###xml 639 661 619 641 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0004736-g003">Fig. 3b, middle panels</xref>
###xml 678 682 658 662 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">high</sup>
###xml 685 688 665 668 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">low</sup>
###xml 693 694 673 674 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 758 762 738 742 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004736-Allman1">[19]</xref>
###xml 914 915 894 895 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 919 920 899 900 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 954 958 934 938 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">high</sup>
###xml 962 963 942 943 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;</sup>
###xml 1276 1277 1248 1249 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 1305 1312 1277 1284 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0004736-g003">Fig. 3c</xref>
###xml 150 154 <span type="species:ncbi:10090">mice</span>
###xml 432 436 <span type="species:ncbi:10090">mice</span>
###xml 489 493 <span type="species:ncbi:10090">mice</span>
###xml 1052 1056 <span type="species:ncbi:10090">mice</span>
###xml 1143 1147 <span type="species:ncbi:10090">mice</span>
In marked contrast to early B cell development in the BM, B220highIgM+IgD+ mature recirculating B cells were significantly diminished in TRAF6-DeltaB mice (12.8+/-1.3% in TRAF6-DeltaB compared to 20.2+/-2.3% in controls, Fig. 3a, top and middle panels). This deficiency is reflected in the absolute cell numbers (Fig. 3a, bottom). In the spleen, the percentage of B cells (CD19+B220+) was also significantly reduced in TRAF6-DeltaB mice (39.2+/-7.1% compared to 50.3+/-4.8% in the control mice, Fig. 3b, upper panels; absolute numbers shown in the lowest panel). The reduction was more prominent in the IgMlowIgDhighAA4.1- mature B cells (Fig. 3b, middle panels) than in the IgMhighIgDlowAA4.1+ transitional B cells, which are their developmental precursors [19]. This finding suggests that TRAF6 regulates the late step of mature B cell development or homeostasis. Within the mature subset, the ratios of the CD21+CD23+ follicular B cell subset and CD21highCD23- marginal zone (MZ) B cell subset were almost identical between TRAF6-DeltaB and control mice. Furthermore, immunohistochemical (IHC) analysis of spleen sections from TRAF6-DeltaB mice revealed normal splenic architecture, with typical T cell areas surrounded by follicular and MZ B cell areas, separated by MOMA1+ metallophilic macrophages (Fig. 3c).
###end p 22
###begin title 23
Cell survival and alternative NF-kappaB signaling are intact in TRAF6-deficient B cells
###end title 23
###begin p 24
###xml 75 82 71 78 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ex vivo</italic>
###xml 373 380 365 372 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0004736-g004">Fig. 4a</xref>
###xml 44 48 <span type="species:ncbi:10090">mice</span>
###xml 141 145 <span type="species:ncbi:10090">mice</span>
###xml 593 597 <span type="species:ncbi:10090">mice</span>
Since mature B cell numbers in TRAF6-DeltaB mice were reduced, we examined ex vivo survival of splenic B cells from TRAF6-DeltaB and control mice cultured with or without serum or in the presence of anti-BCR Ab. Both control and TRAF6-deficient B cells showed similar percentages (approximately 30%) of apoptotic B cells (sub-G0 peak) after 14 hr in the presence of serum (Fig. 4a). This percentage was increased to approximately 50% by serum depletion or BCR crosslinking. Similar results were obtained when transitional B cells isolated from sub-lethally irradiated TRAF6-DeltaB and control mice were used (data not shown). These results suggest that TRAF6 deficiency does not affect B cell survival or susceptibility to apoptosis, arguing that the defects observed were a consequence of impaired fate determination rather than homeostasis.
###end p 24
###begin title 25
Alternative NF-kappaB signal is intact in TRAF6-deficient B cells.
###end title 25
###begin p 26
###xml 75 82 71 78 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ex vivo</italic>
###xml 259 267 255 263 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 61 65 <span type="species:ncbi:10090">mice</span>
(a) Survival of splenic B cells from control or TRAF6-DeltaB mice cultured ex vivo in various conditions indicated. Percentages of apoptotic B cells (sub-G0 peaks) are indicated. (b) Cytoplasmic fractions and nuclear fractions from splenic B cells stimulated in vitro with anti-CD40 antibody (4 microg/ml), recombinant BAFF (2 microg/ml) or LPS (10 microg/ml) for 24 hr immunoblotted with anti-p100/52, anti-RelB and anti-actin antibodies. Results are representative of 2 independent experiments.
###end p 26
###begin p 27
###xml 176 180 176 180 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004736-Mackay1">[20]</xref>
###xml 182 186 182 186 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004736-Patke1">[21]</xref>
###xml 188 192 188 192 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004736-Schneider1">[22]</xref>
###xml 336 340 328 332 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004736-Claudio1">[23]</xref>
###xml 342 346 334 338 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004736-Kayagaki1">[24]</xref>
###xml 595 602 583 590 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0004736-g004">Fig. 4b</xref>
###xml 638 642 626 630 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004736-Claudio1">[23]</xref>
###xml 644 648 632 636 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004736-Kayagaki1">[24]</xref>
###xml 879 886 863 870 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0004736-g005">Fig. 5b</xref>
###xml 1258 1264 1226 1232 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0004736-g002">Fig. 2</xref>
###xml 914 918 <span type="species:ncbi:10090">mice</span>
The TNF family member B cell activating factor (BAFF, also known as BLyS) and its cognate receptor BAFF-R are required for generation and maintenance of the mature B cell pool [20], [21], [22]. It has been reported that signals from BAFF-R activate the alternative NF-kappaB pathway via processing of the NF-kappaB2 protein p100 to p52 [23], [24]. Correspondingly, western blot analysis of control B cell lysates demonstrated that BAFF induced processing of p100 to p52 but did not upregulate p100 or RelB in control B cells, suggesting specific activation of the alternative NF-kappaB pathway (Fig. 4b). Consistent with previous reports [23], [24], CD40 ligation induced processing of NF-kappaB2 as well as upregulation of p100 and RelB, indicating the activation of both canonical and alternative pathways, whereas LPS treatment induced only the canonical pathway. As shown in Fig. 5b, B cells from TRAF6-DeltaB mice exhibited normal processing of p100 to p52 in response to BAFF and anti-CD40 Ab. However, upregulation of p100 and RelB was obviously impaired in response to both LPS and anti-CD40 Ab, suggesting defective canonical NF-kappaB activation. This finding is consistent with the observed defect in IkappaBalpha phosphorylation and degradation (Fig. 2). Therefore, TRAF6 is selectively required for canonical NF-kappaB activation upon TLR or CD40 stimulation but not for activation of the alternative pathway downstream of CD40 or BAFF-R. Again, these results point towards a role for TRAF6 in B cell subset specification rather than in generating survival signals for homeostasis.
###end p 27
###begin title 28
###xml 78 82 <span type="species:ncbi:10090">mice</span>
Germinal center formation in response to TD antigen is intact in TRAF6-DeltaB mice.
###end title 28
###begin p 29
###xml 219 220 219 220 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 224 225 224 225 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 269 271 269 271 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">hi</sup>
###xml 279 280 279 280 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 349 351 349 351 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">hi</sup>
###xml 359 360 359 360 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 53 58 <span type="species:ncbi:9940">sheep</span>
(a) GC formation in the spleen in response to PBS or sheep erythrocyte (SRBC) immunization examined by flow cytometric analysis using fluorescent PNA and antibodies to B220, CD19 and GL7. Profiles of PNA vs. GL7 in B220+CD19+ B cell populations are shown. Ratios of GL7hi and PNA+ B cells in the encircled areas are indicated. (b) Frequencies of GL7hi and PNA+ B cells are quantified. Data are presented as mean+/-SD of five samples of one representative experiment out of 2 independent experiments. (c) Spleen sections were examined for GC formation by immunohistochemical staining with fluorescent PNA (green) and antibodies to B220 (red) and CD3 (blue).
###end p 29
###begin title 30
###xml 98 102 <span type="species:ncbi:10090">mice</span>
Impaired TD antigen-specific IgG production and long-lived plasma cell generation in TRAF6-DeltaB mice
###end title 30
###begin p 31
###xml 237 241 237 241 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004736-Castigli1">[25]</xref>
###xml 243 247 243 247 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004736-Kawabe1">[26]</xref>
###xml 313 319 309 315 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0004736-g002">Fig. 2</xref>
###xml 651 655 639 643 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004736-Cervenak1">[27]</xref>
###xml 673 674 661 662 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 677 678 665 666 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 788 801 768 781 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0004736-g005">Fig. 5a and b</xref>
###xml 842 843 822 823 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 920 927 896 903 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0004736-g005">Fig. 5c</xref>
###xml 210 214 <span type="species:ncbi:10090">mice</span>
###xml 307 311 <span type="species:ncbi:10090">mice</span>
###xml 380 384 <span type="species:ncbi:10090">mice</span>
###xml 423 428 <span type="species:ncbi:9940">sheep</span>
###xml 587 591 <span type="species:ncbi:10090">mice</span>
###xml 619 625 <span type="species:ncbi:3818">peanut</span>
###xml 782 786 <span type="species:ncbi:10090">mice</span>
###xml 914 918 <span type="species:ncbi:10090">mice</span>
TD humoral immune responses, including TD antigen-specific IgG production, GC formation, isotype switching, affinity maturation and generation of memory B and antibody-producing plasma cells, do not develop in mice lacking CD40 or CD154 [25], [26]. Given that CD40 signaling is impaired in the TRAF6-DeltaB mice (Fig. 2), we examined TD immune responses. TRAF6-DeltaB and control mice were immunized intraperitoneally with sheep erythrocytes and examined by flow cytometry and IHC analysis for the formation of GCs. Flow cytometric analysis of spleen cells from TRAF6-DeltaB and control mice stained for the GC markers peanut agglutinin (PNA) and GL7 [27] revealed that GL7+PNA+ GC B cells were induced at comparable ratios (3.80+/-0.86% in TRAF6-DeltaB vs. 3.28+/-0.27% in control mice, Fig. 5a and b). Moreover, IHC analysis showed that PNA+ GCs were present in the B cell areas in both TRAF6-DeltaB and control mice (Fig. 5c), indicating that TRAF6 is not required for GC formation induced by TD antigens.
###end p 31
###begin p 32
###xml 234 241 230 237 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0004736-g006">Fig. 6a</xref>
###xml 388 401 384 397 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0004736-g006">Fig. 6b and c</xref>
###xml 589 602 581 594 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0004736-g006">Fig. 6b and c</xref>
###xml 41 45 <span type="species:ncbi:10090">mice</span>
###xml 228 232 <span type="species:ncbi:10090">mice</span>
###xml 329 333 <span type="species:ncbi:10090">mice</span>
###xml 382 386 <span type="species:ncbi:10090">mice</span>
###xml 543 547 <span type="species:ncbi:10090">mice</span>
TRAF6-DeltaB, CD40-deficient and control mice were also immunized with a separate TD antigen, NP-KLH, and the primary responses were measured 7 days later. NP-specific IgM production was comparable to control and CD40-deficient mice (Fig. 6a). Levels of NP-specific IgG1 and IgG2b were diminished as compared to those in control mice, though still higher than in the CD40-deficient mice (Fig. 6b and c). During the secondary response measured 14 days after boosting, the levels of NP-specific IgG1 and IgG2b were augmented in the TRAF6-DeltaB mice, though still lower than in the control (Fig. 6b and c). These results suggest that antigen-specific isotype switching still occurs in the absence of TRAF6, albeit inefficiently.
###end p 32
###begin title 33
###xml 102 106 <span type="species:ncbi:10090">mice</span>
TD antigen-specific immunoglobulin and long-lived plasma cell production are impaired in TRAF6-DeltaB mice.
###end title 33
###begin p 34
###xml 130 132 130 132 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">st</sup>
###xml 200 202 200 202 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">nd</sup>
###xml 247 254 247 254 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="sec" rid="s4">Methods</xref>
###xml 499 500 497 498 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 548 549 546 547 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 589 593 <span type="species:ncbi:10090">mice</span>
###xml 694 698 <span type="species:ncbi:10090">mice</span>
(a-c) Defective antigen-specific IgG1 and IgG2b production in response to TD antigens for primary response to the TD Ag NP-KLH ("1st", 7days after immunization) and also for the secondary response ("2nd", 14 days after immunization as detailed in Methods). The level of high-affinity (clear bars) and total (black bars) Abs are compared: (a), antigen-specific IgM levels; (b), IgG1; (c), IgG2b. Inset in (b) shows the primary response plotted on a smaller scale. Data are presented as mean+/-SD. *; p<0.05, compare total and high affinity Igs, **; p<0.05, compare control and TRAF6-DeltaB mice. (c) Reduced number of long-lived plasma cells producing NP-specific IgG1 in the BM of TRAF6-DeltaB mice collected 60 days after immunization (as described in a-c), detected by ELISpot assay.
###end p 34
###begin p 35
###xml 88 90 88 90 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">30</sub>
###xml 123 124 123 124 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sub>
###xml 202 206 202 206 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004736-Ahonen1">[14]</xref>
###xml 427 440 427 440 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0004736-g006">Fig. 6b and c</xref>
###xml 336 340 <span type="species:ncbi:10090">mice</span>
###xml 524 528 <span type="species:ncbi:10090">mice</span>
We also examined affinity maturation by comparing the level of antibodies captured by NP30-BSA against those captured by NP3-BSA in an enzyme-linked immunosorbent assay (ELISA), as described previously [14]. About half or less of the total antigen-specific IgG1 and IgG2b was high-affinity Ig during the primary response in the control mice; in the secondary response, almost all the IgG1 and IgG2b antibody was high affinity (Fig. 6b and c). Although total antigen-specific IgG1 and IgG2b levels were lower in TRAF6-DeltaB mice, the proportion of high-affinity antibody was identical to that in the control during secondary responses, suggesting that TRAF6 is not required for affinity maturation, possibly because other TRAFs downstream of CD40 can compensate for the lack of TRAF6.
###end p 35
###begin p 36
###xml 245 252 241 248 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0004736-g006">Fig. 6d</xref>
###xml 181 185 <span type="species:ncbi:10090">mice</span>
###xml 337 341 <span type="species:ncbi:10090">mice</span>
We also measured the terminal differentiation of B cells into plasma cells. The numbers of long-lived antibody-secreting cells in the BM of TRAF6-DeltaB, CD40-deficient and control mice were compared by enzyme-linked immunospot (ELISpot) assay (Fig. 6d). The number of plasma cells secreting NP-specific IgG1 was reduced in TRAF6-DeltaB mice, indicating that TRAF6 plays a role in this terminal differentiation step. Our results indicate that TRAF6 is selectively required for specific CD40 functions during the response to TD antigen.
###end p 36
###begin title 37
###xml 100 104 <span type="species:ncbi:10090">mice</span>
Reduced serum IgM and IgG2b levels and defective TI antigen-specific IgM production in TRAF6-DeltaB mice
###end title 37
###begin p 38
###xml 374 387 366 379 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0004736-g007">Fig. 7a and b</xref>
###xml 108 112 <span type="species:ncbi:10090">mice</span>
###xml 276 280 <span type="species:ncbi:10090">mice</span>
###xml 339 343 <span type="species:ncbi:10090">mice</span>
###xml 442 446 <span type="species:ncbi:10090">mice</span>
We next examined whether TRAF6 also regulates TI immune responses. TRAF6-DeltaB, CD40-deficient and control mice were challenged with either the TI type I antigen NP-LPS or the type II antigen NP-Ficoll. One week after immunization, NP-specific IgM production in TRAF6-DeltaB mice was significantly lower than in control or CD40-deficient mice in response to both antigens (Fig. 7a and b), indicating that TI immune responses in TRAF6-DeltaB mice are poor.
###end p 38
###begin title 39
###xml 100 104 <span type="species:ncbi:10090">mice</span>
Reduced serum IgM and IgG2b levels and defective TI antigen-specific IgM production in TRAF6-DeltaB mice.
###end title 39
###begin p 40
###xml 139 140 139 140 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 152 153 152 153 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 360 361 352 353 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 376 377 368 369 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
(a, b) Defective antigen-specific IgM production in response to the TI antigens NP-Ficoll (TI type 2, a) or with NP-LPS (TI type 1, b). *: p<0.004; **: p<0.04. (c) Serum immunoglobulin levels from unimmunized 14-week-old control (closed circle), TRAF6-DeltaB (open circle) and CD40 KO (open triangle); control; n = 11, TRAF6-DeltaB; n = 12, CD40 KO; n = 5; *: p<0.001 and **: p<0.005.
###end p 40
###begin p 41
###xml 358 365 350 357 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0004736-g007">Fig. 7c</xref>
###xml 61 65 <span type="species:ncbi:10090">mice</span>
###xml 214 218 <span type="species:ncbi:10090">mice</span>
###xml 273 277 <span type="species:ncbi:10090">mice</span>
###xml 352 356 <span type="species:ncbi:10090">mice</span>
Consistent with defects in TI immune responses, TRAF6-DeltaB mice also showed a reduced level of circulating antibody at steady states. When the basal levels of the various classes of Ig in the sera of unimmunized mice were measured by isotype-specific ELISA, TRAF6-DeltaB mice exhibited significantly lower levels of IgM and IgG2b compared to control mice (Fig. 7c).
###end p 41
###begin title 42
TRAF6 is required for B-1a cell development in the peritoneal cavity
###end title 42
###begin p 43
###xml 190 194 190 194 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004736-Carsetti1">[28]</xref>
###xml 196 200 196 200 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004736-Berland1">[29]</xref>
###xml 412 419 404 411 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0004736-g008">Fig. 8a</xref>
###xml 445 446 437 438 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 599 620 583 604 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0004736-g008">Fig. 8b, upper panels</xref>
###xml 677 678 661 662 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 682 683 666 667 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;</sup>
###xml 776 777 756 757 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;</sup>
###xml 781 782 761 762 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 823 845 803 825 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0004736-g008">Fig. 8b, middle panels</xref>
###xml 1011 1018 987 994 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0004736-g008">Fig. 8c</xref>
###xml 1042 1043 1018 1019 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 1049 1053 1025 1029 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004736-Berland1">[29]</xref>
###xml 1118 1139 1094 1115 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0004736-g008">Fig. 8b, lower panels</xref>
###xml 1159 1164 1135 1140 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Cre/+</sup>
###xml 1169 1172 1145 1148 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/+</sup>
###xml 1181 1184 1157 1160 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/+</sup>
###xml 1189 1198 1165 1174 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">flox/flox</sup>
###xml 1242 1243 1218 1219 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 1358 1363 1330 1335 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TRAF6</italic>
###xml 1416 1420 1388 1392 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CD19</italic>
###xml 1694 1701 1666 1673 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0004736-g008">Fig. 8d</xref>
###xml 289 293 <span type="species:ncbi:10090">mice</span>
###xml 370 374 <span type="species:ncbi:10090">mice</span>
###xml 529 533 <span type="species:ncbi:10090">mice</span>
###xml 716 720 <span type="species:ncbi:10090">mice</span>
###xml 906 910 <span type="species:ncbi:10090">mice</span>
###xml 1005 1009 <span type="species:ncbi:10090">mice</span>
###xml 1207 1211 <span type="species:ncbi:10090">mice</span>
###xml 1330 1334 <span type="species:ncbi:10090">mice</span>
###xml 1584 1589 <span type="species:ncbi:10090">mouse</span>
###xml 1655 1659 <span type="species:ncbi:10090">mice</span>
B-1a cells are thought to potentiate responses to certain TI antigens and/or to be the major source of circulating antibody (which is primarily IgM) in the absence of overt antigen exposure [28], [29]. Therefore, we first examined whether B-1a cell development is affected in TRAF6-DeltaB mice. The overall number of cells in the peritoneal exudates of the TRAF6-DeltaB mice was about 40% less than the control (Fig. 8a). The ratio of total CD19+ B cells was significantly reduced in the peritoneal exudate cells of TRAF6-DeltaB mice (44.9+/-6.6% of total cells compared 67.2+/-5.9% in the control, Fig. 8b, upper panels). Within B cell populations, the proportion of the CD11b+CD23- B-1 cell subset in TRAF6-DeltaB mice was particularly affected, with the proportion of CD11b-CD23+ B-2 cells being correspondingly higher (Fig. 8b, middle panels). Since the total B cell number was reduced in TRAF6-DeltaB mice, the percentage of B-2 cells in the total peritoneal exudate was identical to that of control mice (Fig. 8c). Most notably, the CD5+ B-1a [29] cells within the B-1 compartment were almost completely absent (Fig. 8b, lower panels). Because both CD19Cre/+TRAF6+/+ and CD19+/+TRAF6flox/flox control mice showed identical ratios of CD5+ B-1a cells in the peritoneal exudate (data not shown), the deficiency in TRAF6-DeltaB mice could be attributed to TRAF6 deficiency rather than to haploinsufficiency of the CD19 gene. We hypothesized that if either CD40 or the TLRs regulate B-1a cell development through TRAF6, we would see a similar phenotype in the corresponding knockout mouse. However, neither CD40-deficient nor MyD88/TRIF-doubly deficient mice had any deficiency in B-1a cells (Fig. 8d). This intriguing finding suggests that unique TRAF6-dependent receptors are crucial for B-1a cell regulation.
###end p 43
###begin title 44
###xml 14 15 14 15 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 60 64 <span type="species:ncbi:10090">mice</span>
Peritoneal CD5+ B cell population is absent in TRAF6-DeltaB mice.
###end title 44
###begin p 45
###xml 127 128 119 120 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 243 244 231 232 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 335 336 323 324 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;</sup>
###xml 341 342 329 330 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 651 652 629 630 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 80 84 <span type="species:ncbi:10090">mice</span>
###xml 200 204 <span type="species:ncbi:10090">mice</span>
###xml 450 454 <span type="species:ncbi:10090">mice</span>
###xml 544 548 <span type="species:ncbi:10090">mice</span>
###xml 742 746 <span type="species:ncbi:10090">mice</span>
###xml 779 783 <span type="species:ncbi:10090">mice</span>
(a) Total peritoneal exudate cells (PECs) numbers from control and TRAF6-DeltaB mice. (control; n = 5, TRAF6-DeltaB; n = 5) *: p<0.05 (b) Peritoneal exudate cells (PECs) from control and TRAF6-DeltaB mice analyzed by flow cytometry. Total CD19+ B cells (top panels) are subdivided into B-1 and B-2 subsets (middle panels), and the CD23-CD11b+ B-1 subset is further divided into B-1a and B-1b (bottom panels). Results are representative of at least 8 mice. (c) The ratios of each B cell subset in the PECs from control, CD40 KO and TRAF6-DeltaB mice are shown. Data are presented as mean+/-SD. (control; n = 12, CD40 KO; n = 4, TRAF6-DeltaB; n = 8) *: p<0.01 compare to control. (d) Profiles of CD5 expression in B-1 cells from CD40-deficient mice and MyD88/TRIF-doubly deficient mice are analyzed as described in (b).
###end p 45
###begin title 46
Discussion
###end title 46
###begin p 47
###xml 175 179 175 179 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004736-Kobayashi1">[10]</xref>
###xml 314 319 314 319 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TRAF6</italic>
###xml 340 344 340 344 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004736-Lomaga1">[16]</xref>
###xml 346 350 346 350 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004736-Naito1">[17]</xref>
###xml 412 416 <span type="species:ncbi:10090">mice</span>
Here we have investigated the importance of the signaling adaptor TRAF6 to B cell development and function. Our previous study emphasized the role of TRAF6 in innate immunity [10]; however, the role of TRAF6 in lymphocytes and adaptive immunity has not been established. Because of the breadth and severity of the TRAF6-deficient phenotype [16], [17], we generated B cell-specific TRAF6-deficient (TRAF6-DeltaB) mice.
###end p 47
###begin p 48
###xml 264 270 264 270 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0004736-g003">Fig. 3</xref>
###xml 447 454 447 454 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0004736-g002">Fig. 2a</xref>
###xml 558 564 558 564 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0004736-g004">Fig. 4</xref>
###xml 710 714 710 714 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004736-Mackay1">[20]</xref>
###xml 716 720 716 720 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004736-Patke1">[21]</xref>
###xml 722 726 722 726 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004736-Schneider1">[22]</xref>
###xml 806 812 802 808 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0004736-g004">Fig. 4</xref>
Our results demonstrate a broad role for TRAF6 in B lymphocyte development and function. Mature B cell populations in the BM and spleen are reduced, though the pro-, pre- and immature B cells in the BM and transitional B cells in the spleen are of normal numbers (Fig. 3). Although the proliferative response of TRAF6-deficient B cells induced by TLR ligands and CD40 ligation was severely impaired, BCR crosslinking induced normal proliferation (Fig. 2a). Moreover, this impairment does not appear to be the result of increased susceptibility to apoptosis (Fig. 4). It has been shown recently that BAFF-induced survival plays an important role in the maintenance and homeostasis of the peripheral B cell pool [20], [21], [22]. However, we show that signaling from BAFF-R was normal in TRAF6-DeltaB cells (Fig. 4), suggesting that yet-to-be-elucidated molecules activate TRAF6-mediated signals required for generation or maintenance of the mature B cell pool. These results thus suggest a previously unexpected complexity in the nature of signals necessary for these processes.
###end p 48
###begin p 49
###xml 99 103 99 103 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004736-Castigli1">[25]</xref>
###xml 105 109 105 109 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004736-Kawabe1">[26]</xref>
###xml 160 168 160 168 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 170 176 170 176 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0004736-g002">Fig. 2</xref>
###xml 323 329 323 329 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0004736-g006">Fig. 6</xref>
CD40 signaling is known to be important in certain antigen-driven phenomena in TD immune responses [25], [26]. In conjunction with the defect in CD40 signaling in vitro (Fig. 2), we found isotype switching to IgG1 and IgG2b in response to TD antigen was severely impaired, as was the generation of long-lived plasma cells (Fig. 6). Intriguingly, other CD40-dependent processes, such as affinity maturation and GC formation, were unaffected. This finding indicates that a specific subset of CD40 functions operate through TRAF6.
###end p 49
###begin p 50
###xml 59 60 59 60 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 119 125 115 121 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0004736-g008">Fig. 8</xref>
###xml 245 251 241 247 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0004736-g007">Fig. 7</xref>
###xml 347 351 343 347 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004736-Berland1">[29]</xref>
###xml 508 512 497 501 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004736-Berland1">[29]</xref>
###xml 559 567 548 556 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 569 575 558 564 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0004736-g002">Fig. 2</xref>
###xml 702 707 687 692 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Cre/+</sup>
###xml 712 721 697 706 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">flox/flox</sup>
###xml 729 734 714 719 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Cre/+</sup>
###xml 739 745 724 730 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">flox/&#8722;</sup>
###xml 788 793 773 778 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Cre/+</sup>
###xml 798 801 783 786 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/+</sup>
###xml 965 966 946 947 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 988 992 969 973 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004736-Pohl1">[30]</xref>
###xml 1071 1077 1044 1050 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0004736-g002">Figs 2</xref>
###xml 1082 1083 1055 1056 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0004736-g004">4</xref>
###xml 1178 1179 1147 1148 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 1334 1341 1303 1310 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0004736-g008">Fig. 8c</xref>
###xml 1590 1594 1559 1563 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004736-Berland1">[29]</xref>
###xml 1864 1868 1833 1837 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004736-Murakami1">[31]</xref>
###xml 113 117 <span type="species:ncbi:10090">mice</span>
###xml 682 686 <span type="species:ncbi:10090">mice</span>
###xml 802 806 <span type="species:ncbi:10090">mice</span>
###xml 1065 1069 <span type="species:ncbi:10090">mice</span>
###xml 1292 1296 <span type="species:ncbi:10090">mice</span>
###xml 1848 1863 <span type="species:ncbi:10090">transgenic mice</span>
Our most surprising observation is the complete lack of CD5+ B-1a cells in the peritoneal cavity of TRAF6-DeltaB mice (Fig. 8), which is accompanied by lowered basal levels of serum IgM or "natural" antibody and sub-optimal TI immune responses (Fig. 7). Both phenomena are postulated to be largely dependent on peritoneal B-1 cells and MZ B cells [29]. Mutations of positive regulators of BCR signaling, such as PKCbeta, PKCgamma, PI-3K, BLNK, Vav-1 and CD19, are known to result in a reduction in B-1 cells [29]. Since there were no defects in BCR responses in vitro (Fig. 2), we were concerned that the B-1a defect may be the result of CD19 haploinsufficiency of the TRAF6-DeltaB mice, which are CD19Cre/+TRAF6flox/flox or CD19Cre/+TRAF6flox/-. However this was not the case, since CD19Cre/+TRAF6+/+ mice exhibit normal ratios of peritoneal B-1a cells. It has been shown that the combined loss of the NF-kappaB subunits p50 and c-Rel diminishes the peritoneal CD5+ B-1a cell population [30]. Given that the canonical NF-kappaB pathway is impaired in TRAF6-DeltaB mice (Figs 2 and 4), it appears that a TRAF6/NF-kappaB pathway is essential for the development of peritoneal CD5+ B-1a cells. Curiously, neither CD40-deficient nor MyD88/TRIF-doubly deficient (thus defective in TLR signaling) mice have impaired B1-a cell development (Fig. 8c). These results suggest that signals from a receptor(s) other than CD40 or TLRs regulate B-1a cell development or that CD40 and TLRs compensate for each other's loss. The importance of BCR function in B-1 cell development has long been appreciated [29]. However, the involvement of TLRs and other receptors for bacterial products is controversial. It was demonstrated that the administration of LPS or the presence of enteric bacteria is necessary for the development of B-1 cells in anti-RBC autoantibody-transgenic mice [31]. Future experiments will be necessary to identify which cell surface receptors are necessary for TRAF6-mediated B-1 cell development.
###end p 50
###begin p 51
We have demonstrated that TRAF6 is involved in a wide variety of B cell processes. It is crucial for certain CD40 effector functions in B cells during TD humoral immune responses and also for the generation of optimal TI immune responses. In addition, TRAF6 is necessary for B-1a cell development and for the maintenance of the mature B cell pool. Understanding the regulation of this adaptor protein therefore will contribute to our knowledge of B cell function in the development of the immune system and during its response to antigen.
###end p 51
###begin title 52
Materials and Methods
###end title 52
###begin title 53
###xml 0 4 <span type="species:ncbi:10090">Mice</span>
Mice
###end title 53
###begin p 54
###xml 64 68 64 68 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004736-Kobayashi1">[10]</xref>
###xml 74 77 74 77 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">neo</italic>
###xml 98 101 98 101 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">lox</italic>
###xml 170 178 170 178 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 221 225 221 225 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004736-Kobayashi1">[10]</xref>
###xml 348 352 348 352 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004736-Rickert1">[32]</xref>
###xml 547 551 547 551 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004736-Yamamoto1">[33]</xref>
###xml 323 327 <span type="species:ncbi:10090">mice</span>
###xml 441 445 <span type="species:ncbi:10090">mice</span>
###xml 511 515 <span type="species:ncbi:10090">mice</span>
Generation of floxed TRAF6 knock-in ES cells has been described [10]. The neo cassette flanked by loxP sites in the knock-in ES cells was deleted by pMC-Cre transfection in vitro; this deletion was confirmed as described [10] and by Southern blot analysis. Mutant ES clones were injected into C57BL/6 blastocysts. CD19-Cre mice have been described [32] and were obtained from Dr. Alexander Tarakhovsky at the Rockefeller University; CD40 KO mice were purchased from The Jackson Laboratory. MyD88/TRIF double KO mice have been described previously [33]. All animals are maintained in accordance with the applicable portions of the Animal Welfare Act and the DHHS, Guide for the Care and Use of Laboratory Animals.
###end p 54
###begin title 55
###xml 0 8 0 8 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">In vitro</italic>
In vitro proliferation and cytokine production
###end title 55
###begin p 56
###xml 116 117 116 117 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 162 163 162 163 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">5</sup>
###xml 237 241 237 241 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004736-Hemmi1">[34]</xref>
###xml 295 296 295 296 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 381 382 377 378 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sup>
###xml 630 631 618 619 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 303 308 <span type="species:ncbi:10090">mouse</span>
###xml 695 700 <span type="species:ncbi:10090">mouse</span>
Splenic B cells purified by using anti-B220 MACS MicroBeads (Miltenyi Biotec) resulted in a preparation of >95% CD19+ cells. For B cell proliferation assays, 1x105 purified B cells/well were cultured with or without LPS (Sigma), CpG-DNA [34], anti-CD40 antibody (HM40-3, BD Pharmingen) or F(ab')2 anti- mouse Ig Ab (Jackson Immuno Research Laboratories) for 2 days. 0.5 microCi of 3H-thymidine was pulsed for the last 10 hr, and incorporation was measured by liquid scintillation counting. For cytokine production assays, IL-6 in the supernatant of similar cultures stimulated with LPS (10 microg/ml), CpG-DNA (1 microM) or F(ab')2 anti-Ig antibody (20 microg/ml) was determined using an OptEIA mouse IL-6 ELISA set (BD Pharmingen).
###end p 56
###begin title 57
Immunoblots
###end title 57
###begin p 58
###xml 843 854 <span type="species:ncbi:3704">horseradish</span>
###xml 1126 1132 <span type="species:ncbi:9986">Rabbit</span>
###xml 1138 1143 <span type="species:ncbi:10090">mouse</span>
Purified splenic B cells pre-incubated in Hank's balanced salt solution (HBSS) at 37degreesC for 30 min were stimulated with CpG-DNA (4 microM), anti-CD40 Ab (8 microg/ml) or pervanadate for various times and then lysed with lysis buffer containing 1% Triton X-100 and protease and phosphatase inhibitors. For alternative NF-kappaB signaling, cells were stimulated with anti-CD40 Ab (4 microg/ml), recombinant BAFF (2 microg/ml, Pepro Tech) or LPS (10 microg/ml) for 24 hr. Cytoplasmic and nuclear fractions were extracted using a Nuclear Extraction kit (Active Motif). Protein samples were separated by 10% sodium dodecyl sulfate polyacrylamide gel electrophoresis (SDS-PAGE) and transferred onto Immobilon-P PVDF membrane, blocked with 5% or 2.5% milk in PBS with 0.1% Tween-20, incubated with primary Abs overnight at 4degreesC followed by horseradish peroxidase (HRP)-conjugated secondary Abs for 1 hr. Sources of antibodies were as follows: p38, Erk, JNK, Akt, IkBalpha, p-p38, p-Erk, p-Akt, p-IkBalpha (Cell Signaling Technology); p-JNK (BD Transduction laboratories); RelB (Santa Cruz); TRAF6 (MBL); and actin (Sigma). Rabbit anti-mouse p100/52 polyclonal antibody was generously provided by Dr. Amer A. Beg (Columbia University, New York). Blots were developed with ECL substrate (Amersham) and exposed to Kodak BioMax XAR film.
###end p 58
###begin title 59
Flow cytometry
###end title 59
###begin p 60
###xml 248 252 248 252 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004736-McKearn1">[35]</xref>
Antibodies against CD3 (145-2C11), CD5 (53-7.3), CD11b (M1/70), CD16/32 (2.4G2), CD19 (1D3), CD21 (7G6), CD23 (B3B4), CD40 (HM40-3), B220 (RA3-6B2), IgM (R6-60.2) and GL7 were purchased from BD Pharmingen; mAb AA4.1 was purified from the hybridoma [35] kindly provided by Dr. David Allman at the University of Pennsylvania and conjugated to APC by standard techniques. Single-cell suspensions were incubated with anti-CD16/32 (Fc-block) and stained with FITC-, PE-, APC- and biotin-conjugated antibodies, followed by incubation with streptavidin-PerCP-Cy5.5 (Pharmingen). Flow cytometric analysis was performed on a FACSCalibur flow cytometer (BD biosciences) using CellQuest (BD biosciences) and FlowJo (Tree Star, Inc.) software.
###end p 60
###begin title 61
ELISA for serum Ig measurement
###end title 61
###begin p 62
###xml 4 11 4 11 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0004736-g007">Fig. 7c</xref>
###xml 84 88 <span type="species:ncbi:10090">mice</span>
###xml 90 94 <span type="species:ncbi:9925">Goat</span>
###xml 100 105 <span type="species:ncbi:10090">mouse</span>
###xml 181 186 <span type="species:ncbi:10090">mouse</span>
For Fig. 7c, sera were collected from 14-week-old control, TRAF6-DeltaB and CD40 KO mice. Goat anti-mouse Ig (H+L) Ab was used for capture, and isotype-specific HRP-conjugated anti-mouse Ig Abs were used for detection. These and Ig standards were purchased from Southern Biotech Associates Inc.
###end p 62
###begin p 63
###xml 4 10 4 10 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0004736-g006">Figs 6</xref>
###xml 15 24 15 24 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0004736-g007">7a and 7b</xref>
###xml 102 104 102 104 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">30</sub>
###xml 144 145 144 145 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sub>
###xml 234 239 <span type="species:ncbi:10090">mouse</span>
For Figs 6 and 7a and 7b, NP-specific IgM, IgG1 and IgG2b in the sera were measured by capture with NP30-BSA (total antigen-specific Igs), or NP3-BSA (high-affinity Igs) followed by detection with isotype-specific HRP-conjugated anti-mouse Ig Abs.
###end p 63
###begin title 64
Immunizations
###end title 64
###begin p 65
###xml 179 181 175 177 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">67</sub>
###xml 248 249 240 241 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1</sub>
###xml 424 426 412 414 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">30</sub>
###xml 134 138 <span type="species:ncbi:10090">mice</span>
###xml 200 205 <span type="species:ncbi:10090">mouse</span>
###xml 264 269 <span type="species:ncbi:10090">mouse</span>
###xml 361 365 <span type="species:ncbi:10090">mice</span>
###xml 443 448 <span type="species:ncbi:10090">mouse</span>
###xml 523 527 <span type="species:ncbi:10090">mice</span>
###xml 583 588 <span type="species:ncbi:10090">mouse</span>
###xml 686 690 <span type="species:ncbi:10090">mice</span>
###xml 729 734 <span type="species:ncbi:9940">sheep</span>
NP-BSA, NP-KLH, NP-Ficoll and NP-LPS were purchased from Biosearch Technologies Inc. 12-16-week-old control, TRAF6-DeltaB and CD40 KO mice were immunized intraperitoneally with NP67-Ficoll (10 microg/mouse) for TI type-2 immune responses or with NP1-LPS (5 microg/mouse) for TI type-1, and serum Igs were measured after 1 week. For primary TD immune responses, mice were immunized intraperitoneally with alum-precipitated NP30-KLH (200 microg/mouse), and sera were collected 7 days later. For the secondary response, these mice were boosted intraperitoneally with antigen (50 microg/mouse) 14 days after immunization, and sera were collected 14 days after this boost. For GC formation, mice were immunized intraperitoneally with sheep erythrocytes without adjuvant.
###end p 65
###begin title 66
ELISpot assay
###end title 66
###begin p 67
###xml 288 289 288 289 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">6</sup>
###xml 395 396 389 390 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 152 156 <span type="species:ncbi:10090">Mice</span>
###xml 505 510 <span type="species:ncbi:10090">mouse</span>
Long-lived antibody-producing plasma cells were detected by ELISpot assay using a Protein Detector ELISpot Kit (Kirkegaard & Perry Laboratories, Inc.). Mice were immunized with NP-KLH as described above. 60 days after immunization, BM cells were harvested and plated in triplicate at 2x106 cells/well in NP-BSA coated 96-well PVDF plates, which were incubated for 4-6 hr at 37degreesC in a 5% CO2 incubator and then washed with PBS containing 0.05% Tween-20. Spots were developed with HRP-conjugated anti-mouse IgG1 followed by the TrueBlue chromogen substrate, and they were counted under a dissection microscope or with an ELISpot plate reader.
###end p 67
###begin title 68
GC formation
###end title 68
###begin p 69
###xml 33 38 <span type="species:ncbi:9940">sheep</span>
Ten days after immunization with sheep erythrocytes, spleens were collected and subjected to flow cytometry and IHC. For flow cytometry, single-cell suspensions were stained for B220, CD19, GL7 and PNA (Vector Laboratories). For IHC, frozen sections were stained with anti-CD3-PE-Cy5, anti-B220-PE-TexasRed and PNA-FITC or anti-MOMA1-FITC (Serotec).
###end p 69
###begin title 70
Statistical analysis
###end title 70
###begin p 71
###xml 44 45 44 45 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">t</italic>
###xml 120 121 120 121 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
For statistical analysis, we used Student's t-test. A 95% confidence limit was considered significant and is defined as p<0.05.
###end p 71
###begin p 72
###xml 74 78 <span type="species:ncbi:10090">mice</span>
The authors thank Drs. Alexander Tarakhovsky and Kaoru Saijo for CD19-Cre mice; Dr. Amer A. Beg for anti-NF-kappaB2 antibody. T.K. is also grateful to Hinako, Momoko and Kae Kobayashi and to Ryuko Tsutsumi for their support and encouragement.
###end p 72
###begin title 73
References
###end title 73
###begin article-title 74
Mammalian Toll-like receptors.
###end article-title 74
###begin article-title 75
Regulation of growth and proliferation in B cell subpopulations.
###end article-title 75
###begin article-title 76
CpG motifs in bacterial DNA trigger direct B-cell activation.
###end article-title 76
###begin article-title 77
Toll-like receptors and innate immunity.
###end article-title 77
###begin article-title 78
The CD40 antigen and its ligand.
###end article-title 78
###begin article-title 79
The CD40-CD154 interaction in B cell-T cell liaisons.
###end article-title 79
###begin article-title 80
The signaling adaptors and pathways activated by TNF superfamily.
###end article-title 80
###begin article-title 81
TRAF6 is a signal transducer for interleukin-1.
###end article-title 81
###begin article-title 82
All TRAFs are not created equal: common and distinct molecular mechanisms of TRAF-mediated signal transduction.
###end article-title 82
###begin article-title 83
TRAF6 is a critical factor for dendritic cell maturation and development.
###end article-title 83
###begin article-title 84
Activation of NF-kappaB by RANK requires tumor necrosis factor receptor-associated factor (TRAF) 6 and NF-kappaB-inducing kinase. Identification of a novel TRAF6 interaction motif.
###end article-title 84
###begin article-title 85
CD40-tumor necrosis factor receptor-associated factor (TRAF) interactions: regulation of CD40 signaling through multiple TRAF binding sites and TRAF hetero-oligomerization.
###end article-title 85
###begin article-title 86
Distinct molecular mechanism for initiating TRAF6 signalling.
###end article-title 86
###begin article-title 87
The CD40-TRAF6 axis controls affinity maturation and the generation of long-lived plasma cells.
###end article-title 87
###begin article-title 88
The binding site for TRAF2 and TRAF3 but not for TRAF6 is essential for CD40-mediated immunoglobulin class switching.
###end article-title 88
###begin article-title 89
TRAF6 deficiency results in osteopetrosis and defective interleukin-1, CD40, and LPS signaling.
###end article-title 89
###begin article-title 90
###xml 105 109 <span type="species:ncbi:10090">mice</span>
Severe osteopetrosis, defective interleukin-1 signalling and lymph node organogenesis in TRAF6-deficient mice.
###end article-title 90
###begin article-title 91
TRAF6 is a T cell-intrinsic negative regulator required for the maintenance of immune homeostasis.
###end article-title 91
###begin article-title 92
Resolution of three nonproliferative immature splenic B cell subsets reveals multiple selection points during peripheral B cell maturation.
###end article-title 92
###begin article-title 93
BAFF AND APRIL: a tutorial on B cell survival.
###end article-title 93
###begin article-title 94
Survival signaling in resting B cells.
###end article-title 94
###begin article-title 95
BAFF and the regulation of B cell survival.
###end article-title 95
###begin article-title 96
BAFF-induced NEMO-independent processing of NF-kappa B2 in maturing B cells.
###end article-title 96
###begin article-title 97
BAFF/BLyS receptor 3 binds the B cell survival factor BAFF ligand through a discrete surface loop and promotes processing of NF-kappaB2.
###end article-title 97
###begin article-title 98
###xml 15 19 <span type="species:ncbi:10090">mice</span>
CD40-deficient mice generated by recombination-activating gene-2-deficient blastocyst complementation.
###end article-title 98
###begin article-title 99
###xml 39 43 <span type="species:ncbi:10090">mice</span>
The immune responses in CD40-deficient mice: impaired immunoglobulin class switching and germinal center formation.
###end article-title 99
###begin article-title 100
Differential expression of GL7 activation antigen on bone marrow B cell subpopulations and peripheral B cells.
###end article-title 100
###begin article-title 101
###xml 37 42 <span type="species:ncbi:10090">mouse</span>
###xml 47 50 <span type="species:ncbi:9606">man</span>
Peripheral development of B cells in mouse and man.
###end article-title 101
###begin article-title 102
Origins and functions of B-1 cells with notes on the role of CD5.
###end article-title 102
###begin article-title 103
The combined absence of NF-kappa B1 and c-Rel reveals that overlapping roles for these transcription factors in the B cell lineage are restricted to the activation and function of mature cells.
###end article-title 103
###begin article-title 104
###xml 124 139 <span type="species:ncbi:10090">transgenic mice</span>
Effects of breeding environments on generation and activation of autoreactive B-1 cells in anti-red blood cell autoantibody transgenic mice.
###end article-title 104
###begin article-title 105
###xml 51 55 <span type="species:ncbi:10090">mice</span>
B lymphocyte-specific, Cre-mediated mutagenesis in mice.
###end article-title 105
###begin article-title 106
Role of adaptor TRIF in the MyD88-independent toll-like receptor signaling pathway.
###end article-title 106
###begin article-title 107
A Toll-like receptor recognizes bacterial DNA.
###end article-title 107
###begin article-title 108
Cell surface antigens expressed by subsets of pre-B cells and B cells.
###end article-title 108
###begin p 109
###xml 0 21 0 21 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Competing Interests: </bold>
Competing Interests: The authors have declared that no competing interests exist.
###end p 109
###begin p 110
###xml 0 9 0 9 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Funding: </bold>
Funding: This work was supported in part by National Institutes of Health grants RO1-AI32592, P01-AI43260 (to J.G.M and Y.C.). The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.
###end p 110

